| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/33715009_HAS_TOPIC_C0003864> <https://research.tib.eu/covid-19/entity/33715009_HAS_TOPIC_C0021760> <https://research.tib.eu/covid-19/entity/33715009_HAS_TOPIC_C0040298> <https://research.tib.eu/covid-19/entity/33715009_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/33715009_HAS_TOPIC_C0162323> <https://research.tib.eu/covid-19/entity/33715009_HAS_TOPIC_C0302189> <https://research.tib.eu/covid-19/entity/33715009_HAS_TOPIC_C0919747> <https://research.tib.eu/covid-19/entity/33715009_HAS_TOPIC_C0948245> <https://research.tib.eu/covid-19/entity/33715009_HAS_TOPIC_C3658313> <https://research.tib.eu/covid-19/entity/33715009_HAS_TOPIC_C4039583> <https://research.tib.eu/covid-19/entity/33715009_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/33715009_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/33715009_HAS_TOPIC_C5392141>
?:authorAffiliation	[\'Laboratory of Immune Regulation, WPI Immunology Frontier Research Center, Osaka University, Suita City, Osaka, Japan.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Kishimoto_Tadamitsu>
?:doi	10.1093/intimm/dxab011
?:doi	<https://research.tib.eu/covid-19/entity/10.1093/intimm/dxab011>
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article> <https://research.tib.eu/covid-19/entity/Review>
?:journal	International immunology
is ?:pmid of	<https://research.tib.eu/covid-19/entity/33715009>
?:pmid	<https://research.tib.eu/covid-19/entity/33715009>
?:pmid	33715009
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	2.167
?:rankingScore_hIndex	121
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/C1609165_INHIBITS_C1334122> <https://research.tib.eu/covid-19/entity/C1609165_TREATS_C0012634> <https://research.tib.eu/covid-19/entity/C1609165_TREATS_C2905612> <https://research.tib.eu/covid-19/entity/C2740854_TREATS_C1290886>
?:title	IL-6: from arthritis to CAR-T-cell therapy and COVID-19.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2021

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/33715009>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/33715009>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all